Takashi Matsumoto

5PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 07, 2026
Prognostic significance of non-muscle-invasive late recurrence after intravesical bacillus Calmette-Guérin therapy in bladder cancer: a multicenter, retrospective real-world study (the Japan Urological Oncology Group).

|Jan 16, 2026
Age-stratified outcomes of radical cystectomy for muscle-invasive bladder cancer: a nationwide multicenter study of 1867 patients in Japan.

Taketo Kawai, Jun Miki, Rikiya Taoka

|Dec 01, 2025
A randomized controlled phase III trial on continued or paused PD-1 pathway blockade for patients with advanced renal cell carcinoma (JCOG1905, STOP study): a study protocol.

Takashi Matsumoto, Tokiyoshi Tanegashima, Ario Takeuchi

|Jun 06, 2024
Real-world treatment trends for patients with advanced prostate cancer and renal cell carcinoma and their cost-a survey in Japan.

Takahiro Osawa, Keita Sasaki, Ryunosuke Machida

|Oct 28, 2022
Effectiveness and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases in real-world practice: A multi-institutional study.

Takashi Matsumoto, Yoshifumi Hori, Masaki Shiota

Pageof 1

Frequent Collaborators

2 joint publications

Keita Sasaki

2 joint publications

Shingo Hatakeyama

2 joint publications

Katsuyoshi Hashine

2 joint publications

Tomokazu Sazuka